The aims were:
1. To show commercially available OTC topical products that contain CBD, fail to live up to the claimed content of CBD
2. To show commercially available OTC topical products that contain CBD, fail to deliver a therapeutically effective amount of CBD to the skin layers involved in the pathogenesis of common skin diseases
Did they succeed? Yes. But to what end?
I am slightly disappointed with this move for several reasons:
1. None of those OTC products were FDA approved I am assuming. If you are going to compete, go out and compete against topical products that have been approved.
2. One must question the quality of such OTC products when they all contain not even 20% concentration in the whole bottle, which could mean even the concentration that was in there was so badly diluted or spoiled, it was a no contest.
3. The Permetrex technology used needs to stand up against other products that are used for treating Acne, Derma, and Psoriasis. Not some ointment or some cream people use for pain or repair.
4. This was a test against OTC products, not pharmaceutical products. Does anyone else see something wrong here? Has he changed his mind about going pharmaceutical? If he believes in the technology, why not compare to other pharmaceutical products?
We all know the technology works Matt!
But we still don’t really know to what end against world class products.
I am Just being critical.
- Forums
- ASX - By Stock
- BOT
- Ann: Permetrex Outperforms Other CBD Topical Products
Ann: Permetrex Outperforms Other CBD Topical Products, page-53
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $669.7M |
Open | High | Low | Value | Volume |
37.0¢ | 38.0¢ | 36.5¢ | $733.1K | 1.968M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 322835 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 130118 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
17 | 307943 | 0.370 |
10 | 278460 | 0.365 |
9 | 252187 | 0.360 |
8 | 167011 | 0.355 |
8 | 518350 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.380 | 1068380 | 21 |
0.385 | 238502 | 8 |
0.390 | 373662 | 21 |
0.395 | 378120 | 10 |
0.400 | 876366 | 23 |
Last trade - 13.16pm 15/08/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO & Managing Director
Charles Armstrong
CEO & Managing Director
SPONSORED BY The Market Online